Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
Adam S. Kittai(The Ohio State University Wexner Medical Center), Philip A. Thompson(The University of Texas MD Anderson Cancer Center), Levanto Schachter(Oregon Health & Science University), Jennifer A. Woyach(The Ohio State University), Mark R. Dowling(The Royal Melbourne Hospital), Nitin Jain(The University of Texas MD Anderson Cancer Center), Deborah M. Stephens(University of North Carolina at Chapel Hill), Emily Blyth(Westmead Hospital), Caron A. Jacobson(Broad Institute), Aditi Saha(Moffitt Cancer Center), Caitlyn Duffy(Harvard University), Kerry A. Rogers(The Ohio State University), Erin M. Parry(Harvard University), Seema A. Bhat(The Ohio State University), Mazyar Shadman(University of Washington), David A. Bond(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Christine McCarthy(City Of Hope National Medical Center), P Manoj(Oregon Health & Science University), Matthew S. Davids(Dana-Farber Cancer Institute), Hamish W Scott(St Vincent’s Private Hospital Sydney), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Vinay Vanguru(Royal Prince Alfred Hospital), Jayastu Senapati(The University of Texas MD Anderson Cancer Center), Ying Huang(Marshall University), Julio C. Chávez(Moffitt Cancer Center), Zulfa Omer(University of Cincinnati), Carrie Ho(University of Washington), Cecelia Miller, William G. Wierda(The University of Texas MD Anderson Cancer Center), Kevin H. Lin(Harvard University), John C. Byrd(The Ohio State University), Jamie P Dela Cruz(Harvard University), Tanya Siddiqi(City Of Hope National Medical Center)
Cited by 43
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k